Calidi Biotherapeutics
CLDI
CLDI
23 hedge funds and large institutions have $2.85M invested in Calidi Biotherapeutics in 2023 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
19% less capital invested
Capital invested by funds: $3.54M → $2.85M (-$685K)
Holders
23
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$154K | |
| 2 | +$154K | |
| 3 | +$143K | |
| 4 |
SAMC
Spectrum Asset Management (California)
Newport Beach,
California
|
+$126K |
| 5 |
MF
Magnetar Financial
Evanston,
Illinois
|
+$75.6K |
Top Sellers
| 1 | -$416K | |
| 2 | -$219K | |
| 3 | -$30.5K | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$332 |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$33 |